Sheaff Brock Investment Advisors LLC Lowers Stake in HCA Healthcare Inc (NYSE:HCA)

Sheaff Brock Investment Advisors LLC lowered its stake in shares of HCA Healthcare Inc (NYSE:HCA) by 8.3% in the second quarter, HoldingsChannel.com reports. The firm owned 3,335 shares of the company’s stock after selling 300 shares during the period. Sheaff Brock Investment Advisors LLC’s holdings in HCA Healthcare were worth $451,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Westside Investment Management Inc. acquired a new stake in HCA Healthcare during the 2nd quarter worth approximately $34,000. NEXT Financial Group Inc acquired a new stake in HCA Healthcare during the 2nd quarter worth approximately $43,000. Financial Gravity Wealth Inc. acquired a new stake in HCA Healthcare during the 1st quarter worth approximately $47,000. Valeo Financial Advisors LLC acquired a new stake in HCA Healthcare during the 1st quarter worth approximately $66,000. Finally, Rational Advisors LLC lifted its holdings in HCA Healthcare by 5,118.2% during the 1st quarter. Rational Advisors LLC now owns 574 shares of the company’s stock worth $75,000 after buying an additional 563 shares in the last quarter. 70.23% of the stock is owned by hedge funds and other institutional investors.

Shares of HCA traded down $3.08 during midday trading on Wednesday, reaching $122.72. The stock had a trading volume of 421,515 shares, compared to its average volume of 1,741,663. HCA Healthcare Inc has a 1-year low of $110.31 and a 1-year high of $147.42. The business has a fifty day moving average price of $135.68. The firm has a market capitalization of $42.86 billion, a P/E ratio of 12.56, a price-to-earnings-growth ratio of 1.09 and a beta of 0.85.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 30th. The company reported $2.21 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.49 by ($0.28). HCA Healthcare had a net margin of 7.46% and a negative return on equity of 135.90%. The firm had revenue of $12.60 billion during the quarter, compared to analyst estimates of $12.61 billion. During the same quarter in the previous year, the business posted $2.29 earnings per share. HCA Healthcare’s revenue for the quarter was up 9.3% compared to the same quarter last year. On average, sell-side analysts predict that HCA Healthcare Inc will post 10.35 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Tuesday, September 3rd will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, August 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.30%. HCA Healthcare’s payout ratio is 16.38%.

A number of equities research analysts have issued reports on the stock. UBS Group increased their target price on shares of HCA Healthcare from $172.00 to $181.00 and gave the stock a “buy” rating in a report on Monday, June 24th. Barclays reduced their target price on shares of HCA Healthcare from $155.00 to $145.00 and set an “overweight” rating on the stock in a report on Wednesday, April 17th. Jefferies Financial Group set a $158.00 target price on shares of HCA Healthcare and gave the stock a “buy” rating in a report on Wednesday, April 17th. Stephens set a $150.00 target price on shares of HCA Healthcare and gave the stock a “buy” rating in a report on Wednesday, August 7th. Finally, Deutsche Bank increased their target price on shares of HCA Healthcare from $160.00 to $165.00 and gave the stock a “buy” rating in a report on Wednesday, May 1st. Two analysts have rated the stock with a sell rating, two have issued a hold rating and seventeen have given a buy rating to the company’s stock. HCA Healthcare currently has an average rating of “Buy” and a consensus target price of $153.35.

In related news, major shareholder Patricia F. Elcan bought 250 shares of the company’s stock in a transaction that occurred on Tuesday, August 6th. The shares were purchased at an average cost of $124.10 per share, with a total value of $31,025.00. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Robert A. Waterman sold 33,786 shares of the stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $134.98, for a total transaction of $4,560,434.28. Following the completion of the transaction, the senior vice president now directly owns 279,551 shares in the company, valued at $37,733,793.98. The disclosure for this sale can be found here. 2.70% of the stock is currently owned by company insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Article: Price-Sales Ratio

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit